dc.contributor.author | Baple, EL | |
dc.contributor.author | Scott, RH | |
dc.contributor.author | Banka, S | |
dc.contributor.author | Buchanan, J | |
dc.contributor.author | Fish, L | |
dc.contributor.author | Wynn, S | |
dc.contributor.author | Wilkinson, D | |
dc.contributor.author | Ellard, S | |
dc.contributor.author | MacArthur, DG | |
dc.contributor.author | Stark, Z | |
dc.date.accessioned | 2024-05-10T10:29:31Z | |
dc.date.available | 2024-05-09 | |
dc.date.available | 2024-05-10T10:29:31Z | |
dc.date.issued | 19-06-2024 | |
dc.identifier.citation | Baple, E.L., Scott, R.H., Banka, S. et al. Exploring the benefits, harms and costs of genomic newborn screening for rare diseases. Nat Med (2024). https://doi.org/10.1038/s41591-024-03055-x | |
dc.identifier.issn | 1546-170X | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/96780 | |
dc.publisher | Nature Research | en_US |
dc.relation.ispartof | Nature Medicine | |
dc.rights | The version of record of this article, first published in Nature Medicine, is available online at Publisher’s website: doi.org/10.1038/s41591-024-03055-x | |
dc.title | Exploring the benefits, harms, and costs of genomic newborn screening for rare diseases | en_US |
dc.type | Article | en_US |
dc.rights.holder | © 2024, Springer Nature America, Inc. | |
dc.identifier.doi | doi.org/10.1038/s41591-024-03055-x | |
pubs.notes | Not known | en_US |
pubs.publication-status | Accepted | en_US |
dcterms.dateAccepted | 2024-05-09 | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |